通过小分子抑制剂加速CAR-T细胞疗法
Katrin Mestermann1,2, Andoni Garitano-Trojaola3, Michael Hudecek3,4
1Medizinische Klinik und Poliklinik II, Lehrstuhl für zelluläre Immuntherapie, Universitätsklinikum Würzburg, Haus E4-/Raum 4.06, Versbacher Straße 5, 97078, Würzburg, Germany. Mestermann_K@ukw.de.
概括
小分子抑制剂在改善仿真抗原受体T细胞治疗各种癌症方面表现有前途. 这些药物可以帮助制造,提高效率,减少副作用,为难以治疗的癌症提供新的希望.
科学领域:
- 免疫治疗是一种免疫疗法.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 化学抗原受体 (CAR) T细胞疗法已经推进了B细胞恶性瘤治疗.
- 由于抗原损失,瘤微环境和可访问性问题,在急性髓性白血病和固体瘤中有效性有限.
- 卡尔T细胞疗法面临着制造方面的挑战和重大毒性,如细胞因子释放综合征和神经毒性.
研究的目的:
- 审查小分子抑制剂在增强CAR T细胞治疗中的潜力.
- 探索这些抑制剂如何克服CAR T细胞疗法的当前局限性.
- 突出结合策略对更广泛的癌症治疗的承诺.
主要方法:
- 对临床前数据和对将小分子抑制剂与CAR T细胞治疗结合的临床兴趣的审查.
- 分析小分子抑制剂在CAR T细胞制造,疗效和安全中的作用.
- 对信号通路抑制剂进行检查,以改善CAR T细胞治疗结果.
主要成果:
- 小分子抑制剂可以促进CAR T细胞的制造.
- 这些抑制剂显示出增强抗瘤疗效的潜力,对抗血液和固体瘤.
- 组合策略可以减轻与CAR T细胞治疗相关的严重副作用.
结论:
- 小分子抑制剂代表了一种有前途的方法来改进和扩大CAR T细胞治疗的应用.
- 这些组合策略的进一步研究和临床探索是有必要的.
- 这种方法有可能为耐药癌症提供更有效的治疗方法.
相关概念视频
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


